TP53 and cancer: Here, we show that treatment with nonthermal plasma dissolved in a liquid (liquid plasma) causes apoptosis in heterogeneous populations of DDR-defective cancer cells harboring a p53 deficiency or mutations, an ATM or BRCA1 deficiency, either in single culture or in coculture with healthy cells or other heterogeneous cancer cells.